MitoCanada

Nutrition and Specific Mito Disorders

As mitochondrial disease represents over 350 different diagnoses, it makes sense that nutrition can play different roles depending on the underlying condition.

In some disorders, nutrition strategies are focused on preventing metabolic crisis; in others, the goal may be to reduce catabolic stress, support muscle health, or complement diagnosis-specific therapies. Broad clinical care standards emphasize individualized planning and avoiding metabolic stressors (like prolonged fasting), with diagnosis-specific guidance helping further shape nutrition approaches.

For FAOD, nutrition is often a central part of disease management. Because the body many not be able to use fats effectively for energy, maintaining a reliable fuel supply (often emphasizing carbohydrates) and avoiding fasting is critical. Clinical and guideline literature repeatedly highlights:

MELAS can involve high metabolic demand and multi-system symptoms (including GI and nutrition challenges), so nutrition strategies often emphasize maintaining energy balance and preventing catabolic stress during illness or poor intake.

Targeted supplementation is sometimes discussed in MELAS, most notably arginine and/or citrulline in relation to stroke-like episodes. The literature includes supportive reports and reviews, but consensus guidance also notes limitations and ongoing debate about strength of evidence and clinical use.

In MELAS, nutrition care often focuses on steady intake, illness-day planning, and discussing targeted therapies (like specific supplements) with a mitochondrial specialist because recommendations vary across clinics and individuals.

When muscle involvement is prominent, nutrition strategies often focus on supporting muscle maintenance and minimizing fatigue by ensuring adequate overall calories and protein, especially if appetite is low or unintentional weight loss is present.

Some research in mitochondrial disease populations (including those with muscle symptoms) suggests that insufficient intake is common, and that higher intakes of macronutrients (including protein) may correspond with better outcomes like muscle strength, lower fatigue, and improved quality of life, though this doesn’t mean “more is always better,” and personalization matters.

For mitochondrial myopathies, nutrition support often prioritizes “enough energy + enough protein,” using practical strategies (small frequent meals, energy-dense additions, smoothies) when fatigue or GI issues make intake difficult.

POLG-related disorders can present very differently from one person to another. Nutrition strategies commonly emphasize preventing catabolic stress (especially during illness or reduced intake) and maintaining consistent energy availability, an approach aligned with broader mitochondrial care standards.

In some POLG-related conditions, seizures can be a major concern, and dietary therapies (such as ketogenic-style approaches) may be considered in specialized contexts (typically for difficult-to-treat refractory epilepsy) under expert supervision, with careful monitoring and individualized risk–benefit discussions.

For POLG, the key nutrition themes are often “avoid catabolic stress, plan for illness, and create individualize dietary approaches with your mito specialist and care team,” especially if seizures or significant GI/nutrition issues are part of the picture.

Because mitochondrial disease includes many different conditions, nutrition approaches are rarely one-size-fits-all. Some disorders rely heavily on nutrition strategies to prevent metabolic crisis, while others focus on maintaining energy balance, supporting muscle health, or managing symptoms. Across many diagnoses, maintaining consistent energy intake and avoiding metabolic stress are key themes. Individualized guidance from a mitochondrial specialist or dietitian is important to determine the best approach.

Fasting and Mito

Fasting can significantly change how the body fuels itself. When you go without food for longer periods, the body shifts away from using incoming carbohydrates and begins relying more on stored fuels (including fats, protein/muscle). For individuals living with mito, where energy production may already be less efficient, this shift can add metabolic stress and may worsen symptoms for some individuals.

Clinical care standards for mitochondrial disease specifically emphasize preventing catabolism (a state where the body breaks down stored energy and tissue) and recommend avoiding prolonged fasting, particularly around illness, procedures or other stressors.

Because mitochondrial disorders are highly variable, always consult the specialist overseeing your mitochondrial disease care before trying fasting, intermittent fasting or any restrictive eating approach. The “right” strategy must match the diagnosis and the individual, not what is trending online.

The Mito Cocktail

Some mitochondrial specialists may recommend a combination of vitamins and mitochondrial cofactors (nutrients that help enzymes do their jobs), often referred to as the mito cocktail. The goal of a mito cocktail is supportive, to help optimize mitochondrial function, reduce metabolic stress, and improve symptom management.

It’s important to know that there is no single standard mito cocktail. Supplement choices (if recommended at all) depend on an individual’s diagnosis, symptoms, age, medications and lab findings. Clinical experts emphasize that while strong randomized trial evidence is limited for many supplements, supplements are often used in practice because some have biologic rationale, relatively favourable safety profiles when monitored, and may be particularly relevant in specific mito conditions.

Specialists may consider supplements because they can help:

  • Support energy production pathways (including oxidative phosphorylation)
  • Provide cofactors needed for mitochondrial enzymes
  • Help manage secondary effects of mitochondrial dysfunction (like oxidative stress)
  • Address suspected or documented nutrient deficiencies

In some mitochondrial disorders, specific supplements are more commonly considered because of the underlying biology. For example, the Mitochondrial Medicine Society care standards note that riboflavin may be considered in ACAD9-related myopathy and that a combination of CoQ10 and riboflavin may be considered for ETFDH gene-related myopathy.

These are often discussed during mito clinc appointments and in patient resources, but not everyone needs them, and dosing/selection should be individualized.

There’s a fair amount of supplement information online that can sound very convincing. But with mitochondrial disease, the right supplement plan depends on the type of diagnosis and the right clinical context. Supplements can interact with medications, affect lab test results and, depending on the individual, may cause side effects.

Before starting, stopping or changing any supplement, it’s strongly recommended that you discuss it with the specialist overseeing your mitochondrial disease care.

Mealtime Approaches to Managing Energy Levels

Energy conservation is an important part of daily living with mito. Because energy production may be limited, everyday activities such as planning, preparing and eating meals can contribute to fatigue.

Mealtime strategies that reduce physical and cognitive effort can help preserve energy for other essential activities while still supporting consistent nutrition. Small adjustments in how and when meals are prepared and eaten make a meaningful difference.

1. Planning meals in advance
Deciding what to eat ahead of time can reduce decision fatigue and help avoid missed meals on lower-energy days. Simple meal plans or rotating familiar meals can support consistency without added stress

2. Sitting while preparing food
Sitting during food prep helps conserve energy, reduces muscle strain, and support safety, especially for individuals with muscle weakness, balance challenges or fatigue.

3. Using convenience options, when needed
Pre-cut produce, frozen meals, canned food, slow cooker and delivery options can be helpful tools, not shortcuts. These options can help maintain nutrition on days when energy is limited.

4. Timing larger meals during periods of higher energy
Eating more substantial meals at times of day when energy is typically better may help reduce fatigue and support digestion. Lighter meals or snacks may feel more manageable during lower-energy periods.

Care partners play a valuable role in supporting consistent nutrition, particularly during periods of illness, increased fatigue, or symptom flare-ups. Assistance with meal preparation, reminders to eat or drink, and flexibility around mealtime expectations can help reduce pressure and support overall well-being.

Managing Food Triggers in Mito

Food-related symptom flare-ups have been a reported experience for some individuals living with mito. Because mito can affect multiple organ systems, including the gastrointestinal tract, muscles, nervous system and autonomic nervous system, responses to food, meal timing and portion size can vary widely from person to person.

Research and clinical care guidelines increasingly recognize that metabolic stress, including prolonged fasting, large energy demands from digestion or rapid shifts in blood sugar, may worsen symptoms in individuals with impaired mitochondrial energy production. Patient reports also highlight that certain foods or eating patterns can contribute to fatigue, gastrointestinal discomfort, headaches, muscle pain or symptom flares.

Commonly reported triggers may include:

  • Skipping meals or prolonged fasting, which can increase metabolic stress and reduce available energy, particularly important for individuals who rely heavily on regular carbohydrate intake
  • Large, heavy meals, which may be more difficult to digest and can temporarily increase fatigue or gastrointestinal symptoms
  • Highly processed foods, which may be lower in essential nutrients and harder for someone individuals to tolerate
  • Excessive caffeine or alcohol, which can affect hydration, sleep, heart rate and nervous system regulation, potentially worsening symptoms in some people.

It’s important to note that these are not universal triggers. Foods or patterns that cause symptoms for one individual may be well tolerated by another.

Keeping a food-and-symptom journal can be a helpful, low-pressure way to notice patterns over time. Recording what is eaten, when meals occur, portion size, and how symptoms change afterward may help individuals and their healthcare providers identify potential triggers and make thoughtful adjustments.

When symptom flare-ups are frequent, severe, or associated with weight loss, dehydration, or declining function, it’s important to discuss these changes with a healthcare provider. Dietitians and mitochondrial specialists can help distinguish food-related triggers from other causes and support safe, individualized nutrition strategies.

Strategies to Enhance Energy Intake

Meeting energy needs can be challenging for some individuals living with mito. Reduced appetite, feeling full quickly (early satiety), nausea, gastrointestinal discomfort, or fatigue related to meal or food preparation can all make it difficult to eat enough to meet the body’s energy demands. Because energy-producing pathways may be less efficient in mito, even small shortfalls in intake can contribute to increased fatigue or symptom flare-ups over time.

The goal of nutrition strategies is to support steady, realistic energy intake while minimizing additional strain on the body.

  • Eating small, frequent meals rather than large portions, which may feel more manageable and help maintain consistent availability throughout the day.t
  • Choosing energy-dense foods (such as nut butters, avocado, olive oil or full-fat dairy, if tolerated) to provide more calories and nutrients in smaller volumes.
  • Adding healthy fats to meals to increase energy intake without significantly increasing portion size
  • Using smoothies, soups or oral nutrition supplements when solid foods are difficult to tolerate or appetite is low

Because nutritional needs and tolerances can vary widely depending on the specific mitochondrial diagnosis, symptoms, and overall health, working with a healthcare provider or dietitian familiar with mitochondrial disease can help tailor these strategies. Personalized guidance can be especially important during periods of illness, stress or unintentional weight loss, when energy needs may change.

Hydration for Energy Support

Adequate hydration is an essential component of nutrition and plays a critical role in how the body produces and uses energy. Water is necessary for circulation, digestion, temperature regulation, and cellular metabolism, all processes that are already under increases strain in mitochondrial disease.

At the cellular level, hydration supports the movement of nutrients, electrolytes, and metabolic by-products in and out of the cells. When fluid levels are low, these processes become less efficient, which can further challenge energy production and worsen symptoms.

For individuals living with mito, even mild dehydration may contribute to increased fatigue, dizziness, headaches, constipation, muscle cramps and difficulty regulating body temperature, symptoms commonly reported across many mitochondrial conditions. Dehydration can also place additional stress on the cardiovascular and nervous systems, which may already be affected.

Consider the folowing:

  • Sip fluids regularly throughout the day, rather than drinking large amounts at once, to support steady absorption and avoid sudden fluid shifts
  • Include water-rich foods such as soups, fruits, and vegetables, which can contribute to daily fluid intake
  • Consider electrolyte-containing fluids, if recommended by a healthcare provider, especially during illness, hot weather, or periods of increased physical stress.

Individual fluid needs vary. Individuals with cardiac involvement, kidney disease, gastrointestinal symptoms or autonomic dysfunction (e.g., dizziness, temperature regulation, feeling faint, headaches) may require more personalized hydration strategies. Always speak with a healthcare provider before making significant changes to fluid or electrolyte intake.

Building a Well-Balanced, Nutrient-Dense Diet

A well-balanced diet provides a steady supply of fuel and essential nutrients that cells rely on to produce energy and maintain cellular function. In mitochondrial disease, where energy-producing pathways may be less efficient, consistent access to high-quality nutrition becomes especially important.

Rather than relying on one primary fuel source, a balanced approach supports multiple energy pathways and helps reduce metabolic stress on the body. Nutrient-dense foods, those that provide vitamins, minerals and energy without excessive calories, can help support energy levels, muscle function, and overall resilience.

1. Regular meals and snacks
Eating at consistent intervals helps maintain stable energy availability and may reduce fatigue, dizziness or symptom flare-ups associated with low energy stores.

2. Complex carbohydrates
These are foods that digest more slowly, providing a steady release of glucose, and longer-lasting energy, which many cells rely on for energy. They also help avoid rapid spikes and drops in sugar.

3. High-quality proteins
Provide essential amino acids that supports muscle maintenance, tissue repair and immune function. Adequate protein intake is important for preserving strength, especially for individuals with muscle involvement.

4. Healthy fats

Fats provide a concentrated source of energy and support the absorption of fat-soluble vitamins. The ability to use fat for energy varies by mitochondrial diagnosis, so individual guidance from a healthcare provider is important.

Not all individuals with mitochondrial disease can use fats efficiently and recommendations may differ depending on diagnosis and symptoms.

Because the body relies on multiple fuels and interconnected energy-producing pathways to generate ATP, maintaining a balanced intake of carbohydrates, proteins and fats is especially important in mitochondrial disease. When one or more of these pathways is less efficient, the body benefits from having flexible access to different sources.

For this reason, highly restrictive diets are generally discouraged unless they are medically indicated and supervised by a healthcare professional. Limiting entire food groups may increase the risk of nutrient deficiencies and can place additional strain on already challenged energy systems, potentially worsening fatigue and other symptoms.

The Role of Nutrition in Mitochondrial Disease

Nutrition refers to the process of taking in food and fluids to provide the body with energy, support growth, and repair and maintain overall health. Nutriton provides the raw materials mitochondria need to produce energy.

When we eat carbohydrates, they are broken down by digestive enzymes into glucose, fats are broken down by bile from the liver and digestive enzymes into fatty acids, and the protein we eat are broken down by digestive enzymes into amino acids.

Glucose, fatty acids and amino acids (smaller building blocks) are absorbed into the bloodstream and then taken up by muscle, brain and nerve, heart, and liver cells among others.

Inside the cells, mitochondria act as energy factories, using these fuel sources to produce ATP (adenosine triphosphate), the body’s main source of energy.

Energy problems can arise for a number of reasons in mitochondrial disease. Some disorders affect different energy-producing pathways, depending on the underlying genetic cause. Some individuals have difficulty using carbohydrates efficiently, others may struggle to use fats for energy, and some may be affected by multiple pathways.

Understanding which energy pathways are impacted can help explain why certain nutrition strategies are recommended for specific mitochondrial disorders.

Carbohydrate-Based Energy Pathways

What happens: Glucose is processed and ultimately used by mitochondria to create ATP

When this pathway is impaired:

  • The body has difficulty using glucose efficiently for energy, which can lead to energy drops and make the body more reliant on other energy pathways to produce energy.

Fat-Based Energy Pathways

What happens: Fatty acids are transported into mitochondria and broken down to create ATP

When this pathway is impaired:

  • There’s difficulty using fatty acids as a fuel source, which increases reliance on carbohydrates as a backup. During times illness, fasting or missed meals, the body is more likely to run out of usable energy.

* Oxidative Phosphorylation is the pathway impaired in fatty acid oxidation disorders (FAOD)

Protein-Based Energy Pathways

What happens: Some amino acids can be used to support energy production, when needed

When this pathway is impaired:

  • The body has more difficulty using amino acids for backup energy, which can increase fatigue and place extra strain or workload on other energy systems to compensate.

* Protein (amino acid) is not the body’s preferred fuel source because it’s more complex to breakdown, creating more metabolic stress or making cells in the body work harder to create needed energy.

In mitochondrial disease, any of the above energy-producing pathways may be inefficient or impaired. As a result, individuals may experience fatigue, muscle weakness, exercise intolerance, gastrointestinal symptoms, and difficulties maintaining weight or energy balance.

Thoughtful nutrition strategies can help:

  • Support more stable energy production
  • Reduce metabolic stress
  • Prevent nutrient deficiencies
  • Manage symptoms such as fatigue, nausea, and muscle pain

While nutrition is not a cure for mitochondrial disease, it can be a key component of comprehensive care.

Therapies for Mitochondrial Disease – Past, Present, and Future

Science moves fastest when everyone can take part. That’s why MitoCanada is committed to empowering our community with knowledge. By translating cutting-edge mitochondrial research into clear, easy-to-understand summaries, we aim to nurture curiosity, strengthen understanding, and build confidence in the science driving hope and progress.

Lay Summary: Therapies for Mitochondrial Disease – Past, Present, and Future

Authors:

Ball, M., van Bergen, N.J., Compton, A.G., Thorburn, D.R., Rahman, S., & Christodoulou, J. (2025). Therapies for Mitochondrial Disease: Past, Present, and Future. Journal of Inherited Metabolic Disease, 48:e70065.

What’s this research about?

This review examines how treatments for mitochondrial disease (MD) have evolved over the past six decades, and where the field is heading next. The authors trace the journey from the first clinical description of mitochondrial dysfunction in the early 1960s to today’s rapidly expanding era of genetic discovery and targeted therapeutics. 

The review explores both the current management strategies for specific mitochondrial diseases (like CoQ10, thiamine, biotin, and exercise) and the emerging therapeutic frontiers, including dietary approaches, gene and RNA-based therapies, small molecule treatments, and mitochondrial-targeted peptides. It also critically discusses why translating scientific breakthroughs into effective clinical treatments remains challenging, a reflection of the biological complexity and variability of mitochondrial disorders.

Why is this important?

For decades, families affected by mitochondrial disease have faced a difficult reality: although diagnosis has improved, effective treatments remain limited. This review highlights the steady progress being made to change that. The field is shifting from supportive care toward precision medicine, treatments designed to correct the root causes of mitochondrial dysfunction rather than just relieve symptoms.

The authors also discuss why turning scientific discoveries into real treatments is so challenging. Mitochondrial diseases are rare, caused by many different genetic changes, and can look very different from one person to another. It’s also hard to get treatments to reach energy-hungry organs like the brain and heart, where they’re needed most. Researchers are still working to find reliable ways to measure whether a therapy is truly helping, both through biomarkers (measurable signs in the body that show how the disease is behaving) and outcome measures (tests or observations that show whether a treatment is improving health or quality of life).

Even with these challenges, the review makes it clear that mitochondrial medicine is moving forward faster than ever, powered by international teamwork, strong patient involvement, and innovative clinical trial design.

How did they study this?

Instead of focusing on one experiment, the authors brought together decades of research to paint a clear picture of where mitochondrial medicine stands today. They reviewed scientific papers, clinical trial results, and case studies that explored everything from well-known vitamin and cofactor therapies to the latest gene-and cell-based treatments.

To make sense of so much information, they grouped their findings into themes, ranging from long-used “mito-cocktail” supplements to exciting new areas such as boosting NAD+ levels, regulating cell-energy pathways (like mTOR), and developing gene therapies. By looking closely at both the successes and the setbacks, the authors highlight which treatments are showing real promise, which still need more study, and what lessons can guide future breakthroughs.

What did they find?

1. Current therapies

Right now, there’s no single cure for mitochondrial disease, so most treatments focus on easing symptoms, supporting energy production, and improving quality of life. However, for a few specific mitochondrial conditions, where doctors understand the exact chemical pathway that’s disrupted, certain vitamins and cofactors can make a measurable difference.

  • Coenzyme Q10 (CoQ10): This molecule helps move electrons inside mitochondria, a key step in producing energy. In people with primary CoQ10 deficiency, whose bodies don’t make enough CoQ10, taking supplements can improve kidney and nerve function. Results vary, though, since CoQ10 doesn’t always reach the brain efficiently.
  • Thiamine (Vitamin B1): Helps enzymes that convert food into energy. When taken early, it can improve neurological symptoms in thiamine-responsive basal ganglia disease and some forms of pyruvate dehydrogenase complex deficiency
  • Biotin (Vitamin B7): Needed for several enzymes that process fats and proteins. Lifelong biotin supplementation can prevent or reverse neurological and skin symptoms in people with biotinidase deficiency.
  • Riboflavin (Vitamin B2): Supports key mitochondrial enzymes. High-dose riboflavin has helped many people with ACAD9 deficiency and multiple acyl-CoA dehydrogenase deficiency regain strength and reduce fatigue..

Many people with mitochondrial disease also take nutritional supplements, often referred to as a “mitochondrial cocktail.” While the scientific evidence for their benefit is mixed, these supplements are generally safe and sometimes help with energy and stamina.

Exercise therapy is another proven, non-drug approach. Gentle, progressive endurance or resistance training, when done under supervision, can stimulate the growth of new mitochondria, improve muscle strength, and enhance daily functioning and well-being.


2.
Emerging and experimental therapies

Researchers around the world are testing a variety of new treatments aimed at fixing or compensating for mitochondrial malfunction. Here are some of the most promising areas of discovery:

  • Dietary approaches: High-fat, low-carbohydrate ketogenic diets and specialized fats such as triheptanoin may give cells an alternate energy source, helping reduce seizures or muscle weakness in certain conditions. Because these diets can sometimes cause side effects, they must be used with medical guidance.
  • Stimulating mitochondrial growth: Some drugs, like bezafibrate, REN001, and omaveloxolone try to “switch on” the body’s own pathways that make and maintain mitochondria. Early studies show improvements in some cellular markers and mild symptom relief, though large-scale benefits have yet to be proven.
  • Restoring NAD⁺ balance: NAD⁺ is a molecule essential for energy production, and levels can drop in mitochondrial disease. Supplements such as
     nicotinamide riboside, nicotinamide mononucleotide, and KL1333 aim to restore these levels. Early trials suggest they may boost energy metabolism and reduce fatigue.
  • Antioxidant therapies: Because damaged mitochondria produce harmful reactive oxygen species (ROS), antioxidants can help limit that damage. Idebenone, vatiquinone (EPI-743), and sonlicromanol (KH176) are being tested for their ability to protect cells and support energy production. Idebenone has already shown benefit for vision in some people with Leber hereditary optic neuropathy.
  • Supporting blood flow and oxygen delivery: In certain mitochondrial syndromes like MELAS, supplements such as L-arginine and L-citrulline
     may help widen blood vessels, improving circulation and reducing the risk of “stroke-like” episodes.
  • Modulating energy-sensing pathways: Drugs that act on the mTOR pathway (like rapamycin and everolimus) are showing benefits in laboratory models by reducing inflammation and improving energy balance.
  • Protecting mitochondrial structure: Elamipretide (SS-31) helps stabilize the membranes that hold mitochondria together, protecting them from damage. Some clinical studies show better muscle function and less fatigue, while others found only modest changes, highlighting the complexity of these conditions.
  • Nucleoside replacement: In a few rare forms of mitochondrial DNA depletion (such as TK2 deficiency), therapy with building-block molecules called deoxynucleosides has helped restore mitochondrial DNA and improve survival.
  • Gene Therapies: Researchers are also exploring gene therapies that target the faulty gene itself. The majory of these approaches are experimental and are still early in development

In total, more than 30 clinical trials around the world are now testing therapies like these. None are yet curative, but the variety and sophistication of approaches reflect remarkable momentum. The field is moving from managing symptoms to targeting the root causes of mitochondrial dysfunction, an extraordinary step forward for patients, families, and researchers alike.

What does this mean for mitochondrial disease research?

This review marks an exciting turning point for mitochondrial medicine. For many years, research focused mainly on diagnosing and describing how mitochondrial diseases work. Now, the field is moving beyond understanding the problem, scientists are testing real treatments designed to fix it.

The authors emphasize that the road ahead still requires close teamwork across the globe. Researchers need better tools to study these diseases, including reliable biomarkers that show how the body responds to treatment, and agreed-upon outcome measures that make it easier to compare results between studies. Creating stronger animal models will also help scientists test therapies safely before they reach patients.

Just as important, progress will depend on collaboration, not only between scientists and clinicians, but also with patients, families, and advocacy organizations, like MitoCanada. Well-organized patient registries and international trial networks are key to making rare disease research faster, more efficient, and more inclusive. By working together, the global mito community is transforming years of discovery into a future filled with real treatment possibilities

The research in simple terms

This paper brings together everything scientists currently know about treating mitochondrial disease, from long-used vitamins and dietary strategies to the newest molecular and gene-based therapies being tested in clinics today. It highlights just how far the field has come since the first mitochondrial disorders were described in the 1960s.

While there’s still no single cure, the pace of progress is accelerating. Researchers are learning from both successes and setbacks, building on decades of discovery to design smarter, more targeted therapies. Just as importantly, the paper reflects the growing collaboration among scientists, clinicians, patients, and families, all working together to transform complex research into meaningful, real-world care.

At its heart, this is a story of perseverance and partnership: of a community united by determination to change what’s possible for people living with mitochondrial disease.

Why this matters to the MitoCommunity?

For those living with mitochondrial disease, and for everyone who supports them, this research represents hope backed by evidence. It shows that the global mito community is moving forward together: researchers exploring new frontiers, clinicians testing innovative treatments, and patient advocates ensuring that lived experiences shape every step of progress.

Each study like this adds another piece to the puzzle, helping to build a clearer picture of how to repair, protect, and strengthen the body’s energy-producing cells. These discoveries don’t just aim to extend life, they strive to improve how people live day to day, enhancing energy, independence, and connection.

The paper also reminds us how vital community participation is. Joining registries, contributing to research, and sharing personal stories all help guide future priorities and accelerate breakthroughs. And for donors and partners, it underscores a powerful truth: every investment in mitochondrial research moves us closer to a world where all lives are powered by healthy mitochondria.

Acknowledgment

The authors’ work reflects the incredible progress being made through collaboration across continents, disciplines, and generations of researchers. Their dedication not only advances the science of mitochondrial medicine but also fuels hope for families around the world. Every study like this brings us one step closer to a future where mitochondrial disease can be better understood, treated, and ultimately prevented.

This MitoInsights was reviewed and approved by a member of or members of this publications authorship.

© MitoCanada 2025. Not for adaptation without consent.

Explore the orginial publication or download our layperson article today:

Do you have a question about this article? If so, we’d like to hear from you. Please send us an email!

Go to Top